FASANO, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 1.191
EU - Europa 770
AS - Asia 367
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.333
Nazione #
US - Stati Uniti d'America 1.168
CN - Cina 243
DE - Germania 123
IE - Irlanda 108
UA - Ucraina 89
SE - Svezia 77
KR - Corea 66
FI - Finlandia 65
FR - Francia 58
DK - Danimarca 50
IT - Italia 47
GB - Regno Unito 44
AT - Austria 37
SG - Singapore 35
CA - Canada 22
PL - Polonia 20
RU - Federazione Russa 20
BE - Belgio 13
IN - India 11
GR - Grecia 9
VN - Vietnam 6
JP - Giappone 4
HR - Croazia 3
NL - Olanda 3
CH - Svizzera 2
NG - Nigeria 2
SN - Senegal 2
ES - Italia 1
EU - Europa 1
IR - Iran 1
MX - Messico 1
NO - Norvegia 1
PK - Pakistan 1
Totale 2.333
Città #
Ann Arbor 294
Beijing 209
Chandler 206
Dublin 108
Houston 62
Jacksonville 59
Dearborn 44
Princeton 37
Vienna 37
Medford 31
Villeurbanne 29
Nyköping 28
Ashburn 24
Singapore 24
Torino 21
Warsaw 20
Wilmington 20
Boston 19
Boardman 15
Brussels 13
Falls Church 11
Ottawa 11
Athens 9
Woodbridge 9
New York 8
Milan 7
Verona 7
Toronto 6
Nanjing 5
Norwalk 5
Dong Ket 4
Edinburgh 4
Hefei 4
Fairfield 3
Fuzhou 3
Guangzhou 3
Lachine 3
Redwood City 3
Turin 3
Zagreb 3
Abuja 2
Cambridge 2
Fremont 2
Fürth 2
Hakodate 2
Kunming 2
Redmond 2
Seattle 2
Tokyo 2
Wuhan 2
Xian 2
Zhengzhou 2
Zurich 2
Ardabil 1
Asti 1
Bangalore 1
Buffalo 1
Carpi 1
Changsha 1
Dallas 1
Düsseldorf 1
Groningen 1
Hangzhou 1
Harbin 1
Islamabad 1
Kansas City 1
Konstanz 1
La Jolla 1
Lappeenranta 1
Littleton 1
Monmouth Junction 1
Montréal 1
Mountain View 1
Nanchang 1
Nijmegen 1
Nürnberg 1
Omaha 1
Padova 1
Paris 1
Philadelphia 1
Phoenixville 1
Pune 1
San Juan 1
San Mateo 1
San Mauro Torinese 1
Santa Clara 1
Shanghai 1
Shenyang 1
Sorel-Tracy 1
Southend 1
Taiyuan 1
Tappahannock 1
Tijuana 1
Trondheim 1
Washington 1
Totale 1.479
Nome #
Binding and relaxometric properties of heme complexes with cyanogen bromide fragments of human serum albumin 146
Modulation of the antioxidant activity of HO center dot scavengers by albumin binding: a F-19-NMR study 139
Evidence for a glycidic-lipidic matrix in human neuromelanin, potentially responsible for the enhanced iron sequestering ability of substantia nigra. 132
EFFECT OF IBUPROFEN AND WARFARIN ON THE ALLOSTERIC PROPERTIES OF HAEM-HUMAN SERUM ALBUMIN 128
Thermodynamic analysis of hydration in human serum heme-albumin 120
Nuclear magnetic resonance spectroscopy characterization and iron content determination of human mesencephalic neuromelanin. 115
RELAXOMETRIC CHARACTERIZATION OF HUMAN HEMALBUMIN 113
A New Ytterbium Chelate as Contrast Agent in Chemical Shift Imaging and Temperature Sensitive Probe for MR Spectroscopy 107
Proteome analysis of mesencephalic tissues: evidence for Parkinson's disease. 85
Lymphocyte proteomics of Parkinson’s disease patients reveals cytosckeletal protein dysregulation and oxidative stress 76
Towards Novel Non-Ionic Contrast Agents for Magnetic Resonance Imaging: Synthesis and Characterization of [(Bisphenylamide-DTPA)M(III)] (M = Lu, Y and Gd) 69
Paramagnetic Gd(III)-Fe(III) Heterobimetallic Complexes of DTPA-Bis-Salicylamide 67
Residual substantia nigra neuromelanin in Parkinson's disease is cross-linked to alpha-synuclein. 66
Magnetic investigations of human mesencephalic neuromelanin 64
The proteomic approach in Parkinson's disease. 61
Changes in the two-dimensional electrophoresis pattern of the Parkinson's disease related protein DJ-1 in human SH-SY5Y neuroblastoma cells after dopamine treatment. 60
Ln(III) Chelates for NMR Biomedical Applications 60
Metal ion content in Sepia officinalis melanin 59
Proteomic analysis of dopamine and copper toxicity in SH-SY5Y human neuroblastoma cells expressing alpha-synuclein 59
Nuclear magnetic relaxation dispersion profiles of substantia nigra pars compacta in Parkinson's disease patients are consistent with protein aggregation. 56
Paramagnetic water proton relaxation enhancement: From contrast agents in MRI to reagents for quantitative “in vitro” assays 56
Verification of a Parkinson's disease protein signature in T-lymphocytes by multiple reaction monitoring. 55
Expression proteomics of peripheral blood lymphocytes from Parkinson's disease patients 55
Binding of anti-Parkinson's disease drugs to human serum albumin is allosterically modulated. 55
Alpha-synuclein and Parkinson's disease: a proteomic view. 54
Gd(III) Complexes as Contrast Agents for Magnetic Resonance Imaging: a Proton Relaxation Enhancement Study of the Interaction with Human Serum Albumin 54
PROTEIN-BOUND METAL CHELATES 54
Proteomics as a tool to investigate cell models for dopamine toxicity 53
Relaxometric Determination of the Exchange rate of the coordinated Water Protons in a Neutral Gd(III) Chelate 51
Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration. 43
Prototropic and Water-Exchange Processes in Aqueous Solutions of Gd(III) Chelates 39
Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis. 30
Low noncarbonic buffer power amplifies acute respiratory acid-base disorders in patients with sepsis: An in vitro study 29
Shared and Unique Disease Pathways in Amyotrophic Lateral Sclerosis and Parkinson's Disease Unveiled in Peripheral Blood Mononuclear Cells 8
Totale 2.418
Categoria #
all - tutte 7.132
article - articoli 0
book - libri 0
conference - conferenze 348
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.480


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020361 7 26 37 24 55 70 50 7 21 32 24 8
2020/2021193 29 4 15 4 11 7 25 3 28 25 8 34
2021/2022435 28 25 25 35 27 40 37 27 23 28 66 74
2022/2023509 53 22 23 65 56 132 40 37 50 4 20 7
2023/2024171 31 45 6 10 5 14 11 10 0 3 10 26
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 2.418